Labcyte to Merge with Deerac Fluidics | GenomeWeb
NEW YORK (GenomeWeb News) – Labcyte and Allegro Technologies, which conducts business as Deerac Fluidics, have agreed to merge, the companies said Sunday.
 
Financial terms of the deal were not disclosed.
 
Labcyte offers a droplet ejection technology that is used in compound management, assays, arraying, particle manufacturing, imaging mass spectrometry, and live cell transfer.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.